Close Menu

NEW YORK – Quanterix reported after the close of the market on Wednesday that its third quarter revenues rose 41 percent year over year, driven by an 80 percent increase in product revenues.

For the three months ended Sept. 30, the Billerica, Massachusetts-based company posted Q3 revenues of $14.9 million, up from $10.6 million in Q3 2018, beating the consensus Wall Street estimate of $12.6 million. Excluding $1.3 million recognized in Q3 2018 connected to the termination of a license agreement, revenue was up 62 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.